Retatrutide
Retatrutide
Couldn't load pickup availability
Leave your email and we will let you know the moment Retatrutide is restocked.
Already purchased? Get your instructions
Enter the name and email from your order and we'll send the usage guide for this product.
Research peptide · freeze-dried powder · research grade · 5mg or 30mg vial
About Retatrutide
Retatrutide is a research peptide, a synthetic single-chain molecule designed to act at three receptors at once: GLP-1, GIP and glucagon. We supply it as a freeze-dried powder at research grade, in 5mg and 30mg vials.
Researchers studying Retatrutide are most interested in how the body regulates appetite and blood sugar, how it stores and uses fat, and how signalling at three receptors together differs from signalling at one or two, mostly in cell and animal models.
Specifications
| Detail | Spec |
|---|---|
| Compound | Retatrutide (a triple GLP-1, GIP and glucagon receptor agonist) |
| Form | Freeze-dried powder |
| Grade | Research grade, high purity |
| Vial options | 5mg, 30mg |
For verified researchers
Handling, reconstitution and storage notes are sent to verified buyers through the Blaque Sigma research library with your order confirmation. If you need details before ordering, contact us through the storefront enquiry form.
Research-use disclaimer. This product is supplied for research and laboratory use only by qualified researchers familiar with handling research compounds. It is not intended for human or veterinary consumption, for diagnostic or therapeutic use or for any application in or on the body. By purchasing, you confirm that you are a qualified researcher or professional using this product strictly for research purposes.
General disclaimer. These statements have not been evaluated by a medical regulatory authority. No claim is made regarding the diagnosis, treatment, cure or prevention of any disease. Information here is for reference only and is not medical or scientific advice. Keep out of reach of children and unauthorised persons.
Share
